← Back to Discover
Seven Fleet Capital Management LP
Period ended Jun 30, 2026 · Latest filing Aug 17, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $605,916,390
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- CG ONCOLOGY INC · COM · 156944100 · shares: $134,017,068
- TANGO THERAPEUTICS INC · COM · 87583X109 · shares: $95,660,985
- REVOLUTION MEDICINES INC · COM · 76155X100 · shares: $45,327,191
- PHARVARIS N V · COM · N69605108 · shares: $26,782,245
- LIQUIDIA CORPORATION · COM NEW · 53635D202 · shares: $20,458,957
- ENLIVEN THERAPEUTICS INC · COM · 29337E102 · shares: $18,543,340
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $14,836,369
- AVALO THERAPEUTICS INC · COM NEW · 05338F306 · shares: $14,243,737
- MIRUM PHARMACEUTICALS INC · COM · 604749101 · shares: $12,923,709
- ASSEMBLY BIOSCIENCES INC · COM NEW · 045396207 · shares: $11,902,879
Reported holdings
114 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| CG ONCOLOGY INC | COM | 156944100 | — | 1,439,393 shares | $102,268,873 |
| TANGO THERAPEUTICS INC | COM | 87583X109 | — | 1,909,593 shares | $54,443,081 |
| TANGO THERAPEUTICS INC | COM | 87583X109 | — | 1,318,551 shares | $41,217,904 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 194,363 shares | $36,400,303 |
| CG ONCOLOGY INC | COM | 156944100 | — | 446,843 shares | $31,748,195 |
| PHARVARIS N V | COM | N69605108 | — | 482,524 shares | $16,685,680 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 111,334 shares | $14,836,369 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 289,136 shares | $14,673,652 |
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | — | 182,103 shares | $14,519,072 |
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | — | 110,393 shares | $12,923,709 |
| PHARVARIS N V | COM | N69605108 | — | 291,977 shares | $10,096,565 |
| CYTOKINETICS INC | COM NEW | 23282W605 | — | 118,240 shares | $10,072,866 |
| TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | — | 1,504,400 shares | $9,940,323 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 47,666 shares | $8,926,888 |
| VERADERMICS INC | COMMON STOCK | 922967104 | — | 70,000 shares | $8,605,800 |
| ARRIVENT BIOPHARMA INC | COM | 04272N102 | — | 246,606 shares | $8,567,092 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 438,552 shares | $8,104,441 |
| TARSUS PHARMACEUTICALS INC | COM | 87650L103 | — | 117,067 shares | $7,909,873 |
| XENCOR INC | COM | 98401F105 | — | 368,305 shares | $7,828,524 |
| ROIVANT SCIENCES LTD | SHS | G76279101 | — | 220,126 shares | $7,790,259 |
| CENTURY THERAPEUTICS INC | COM | 15673T100 | — | 2,947,826 shares | $7,222,174 |
| AXSOME THERAPEUTICS INC | COM | 05464T104 | — | 28,826 shares | $7,055,740 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 148,647 shares | $6,992,355 |
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | — | 226,415 shares | $6,221,884 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 332,213 shares | $6,139,296 |
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | — | 74,500 shares | $5,939,885 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 147,510 shares | $5,708,637 |
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | — | 206,732 shares | $5,680,995 |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | — | 45,400 shares | $5,565,132 |
| EDITAS MEDICINE INC | COM | 28106W103 | — | 1,330,500 shares | $4,310,820 |
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | — | 43,672 shares | $4,257,147 |
| MINERVA NEUROSCIENCES INC | COM NEW | 603380205 | — | 754,397 shares | $4,186,903 |
| DAMORA THERAPEUTICS INC | COM NEW | 36322Q206 | — | 154,430 shares | $4,016,724 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 76,250 shares | $3,869,688 |
| ERASCA INC | COM | 29479A108 | — | 210,346 shares | $3,853,539 |
| SUTRO BIOPHARMA INC | COM SHS | 869367201 | — | 159,118 shares | $3,794,182 |
| CENTURY THERAPEUTICS INC | COM | 15673T100 | — | 1,400,000 shares | $3,430,000 |
| DAMORA THERAPEUTICS INC | COM NEW | 36322Q206 | — | 130,000 shares | $3,381,300 |
| RELAY THERAPEUTICS INC | COM | 75943R102 | — | 178,222 shares | $3,334,534 |
| ASCENDIS PHARMA A/S | ORD SHS | K08588103 | — | 11,869 shares | $3,165,700 |
| SAGIMET BIOSCIENCES INC | COM SER A | 786700104 | — | 403,545 shares | $3,119,403 |
| ZAI LAB LTD | ADR | 98887Q104 | — | 136,016 shares | $2,924,756 |
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | — | 714,000 shares | $2,677,500 |
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | — | 4,973 shares | $2,670,252 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | — | 70,164 shares | $2,610,802 |
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 7,540 shares | $2,524,317 |
| RELMADA THERAPEUTICS INC | COM | 75955J402 | — | 348,265 shares | $2,409,994 |
| EUPRAXIA PHARMACEUTICALS INC | COM | 29842P105 | — | 334,785 shares | $2,212,929 |
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | — | 56,900 shares | $2,111,559 |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | — | 33,300 shares | $2,084,468 |
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | — | 21,051 shares | $2,052,051 |
| SAVARA INC | COM | 805111101 | — | 309,103 shares | $1,904,074 |
| EUPRAXIA PHARMACEUTICALS INC | COM | 29842P105 | — | 276,000 shares | $1,824,360 |
| ERASCA INC | COM | 29479A108 | — | 97,661 shares | $1,789,150 |
| C4 THERAPEUTICS INC | COM STK | 12529R107 | — | 381,169 shares | $1,780,059 |
| VAXCYTE INC | COM | 92243G108 | — | 29,800 shares | $1,777,570 |
| CELCUITY INC | COM | 15102K100 | — | 16,252 shares | $1,700,284 |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | — | 77,930 shares | $1,645,046 |
| SAB BIOTHERAPEUTICS INC | COM NEW | 78397T202 | — | 400,000 shares | $1,560,000 |
| ZENTALIS PHARMACEUTICALS INC | COM | 98943L107 | — | 317,600 shares | $1,451,432 |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | — | 26,800 shares | $1,441,572 |
| LEONABIO INC | COM | 04746L203 | — | 154,153 shares | $1,416,666 |
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | — | 37,865 shares | $1,411,229 |
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | — | 371,398 shares | $1,392,743 |
| MINERVA NEUROSCIENCES INC | COM NEW | 603380205 | — | 246,976 shares | $1,370,717 |
| GERON CORP | COM | 374163103 | — | 1,057,228 shares | $1,353,252 |
| SAB BIOTHERAPEUTICS INC | COM NEW | 78397T202 | — | 336,077 shares | $1,310,700 |
| ADLAI NORYTE LTD | SPONSORED ADS | 00704R109 | — | 113,207 shares | $1,301,881 |
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | — | 82,890 shares | $1,238,377 |
| VERADERMICS INC | COMMON STOCK | 922967104 | — | 10,000 shares | $1,229,400 |
| ALKERMES PLC | SHS | G01767105 | — | 23,285 shares | $1,220,018 |
| SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | — | 13,300 shares | $1,180,774 |
| PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | — | 332,613 shares | $1,134,210 |
| ONKURE THERAPEUTICS INC | COM CL A | 68277Q105 | — | 240,963 shares | $1,098,791 |
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | — | 73,300 shares | $1,090,930 |
| AN2 THERAPEUTICS INC | COM | 037326105 | — | 208,946 shares | $1,011,299 |
| CONTINEUM THERAPEUTICS INC | CL A | 21217B100 | — | 60,541 shares | $992,267 |
| TREVI THERAPEUTICS INC | COM | 89532M101 | — | 45,598 shares | $833,430 |
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | — | 230,406 shares | $771,860 |
| INVENTIVA SA | ADS | 46124U107 | — | 200,141 shares | $756,533 |
| ENGENE THERAPEUTICS INC | COM | 29286X101 | — | 411,065 shares | $711,142 |
| LARIMAR THERAPEUTICS INC | COM | 517125100 | — | 230,921 shares | $704,309 |
| INHIBIKASE THERAPEUTICS INC | COM NEW | 45719W205 | — | 346,900 shares | $704,207 |
| NEUROGENE INC | COM | 64135M105 | — | 22,060 shares | $693,787 |
| ISHARES TR | U.S. MED DVC ETF | 464288810 | — | 13,800 shares | $681,858 |
| SILENCE THERAPEUTICS PLC | ADS | 82686Q101 | — | 60,107 shares | $659,975 |
| KRYSTAL BIOTECH INC | COM | 501147102 | — | 1,774 shares | $659,343 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | — | 16,500 shares | $613,965 |
| OPUS GENETICS INC | COM | 67577R102 | — | 143,137 shares | $588,293 |
| PALISADE BIO INC | COM | 696389402 | — | 272,204 shares | $568,906 |
| EVOLUS INC | COM | 30052C107 | — | 78,057 shares | $541,716 |
| UNICYCIVE THERAPEUTICS INC | COM NEW | 90466Y202 | — | 103,400 shares | $521,136 |
| COMPASS THERAPEUTICS INC | COM | 20454B104 | — | 233,066 shares | $510,415 |
| BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | — | 51,024 shares | $510,240 |
| BRIGHT MINDS BIOSCIENCES INC | COM NEW | 10919W405 | — | 6,395 shares | $448,929 |
| PROTHENA CORP PLC | SHS | G72800108 | — | 43,300 shares | $423,907 |
| MONTE ROSA THERAPEUTICS INC | COM | 61225M102 | — | 16,800 shares | $406,560 |
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | — | 31,476 shares | $393,765 |
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | — | 270,233 shares | $362,112 |
| ENTERA BIO LTD | SHS | M40527109 | — | 191,354 shares | $338,697 |